Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-31 @ 4:10 PM
Study NCT ID:
NCT04840394
Status:
COMPLETED
Last Update Posted:
2025-11-12
First Post:
2021-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Sponsor:
Eikon Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-07
First Submit QC Date:
None
Study First Post Date:
2021-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-10
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED